Une étude de cas récemment publiée par le Dr Richard Horowitz met en évidence des changements importants au niveau des biomarqueurs liés à la maladie d'Alzheimer après un traitement contre la maladie de Lyme
Improving biomarkers of inflammation including phosphorylated tau in a patient with chronic Lyme disease/post-treatment Lyme disease syndrome using dapsone combination therapy: A case study and literature review
Richard Horowitz. Review article. Journal of Alzheimer's Disease Reports. First published online April 27, 2026
A full explanation of the article can be found in my Medical Detective Substack: Alzheimer’s Disease & Lyme Disease: Proving For The First Time Ever the Role of MSIDS Factors & The Infection-Amyloid-Phosphorylated Tau Connection!
Please share this with your friends, family and physicians. This article impacts everyone, since we are having a banner year for tick bites! Even if you are not having cognitive issues, this article and Substack has great importance to protect you and your loved ones.
For more information: The Healing Lyme Summit this year, where I am co-host with Dr Myriah Hinchey is: The Neuroinflammation–Brain Protection Summit.
Event: May 9–13, 2026 Encore: May 16–17, 2026It is free to sign up. I will do a larger explanation of why you want to attend this free Summit in the next FB post, because of the implications of this new article and what I found for the Lyme community. Get your spot by signing up today:
